Deep stock research, on demand.

Nvidia enters September 2026 with fundamentals that remain extraordinary in absolute terms: fiscal Q2 2027 revenue of $96.2 billion rose 106% year over year and beat consensus of roughly $92.2 billion, with non-GAAP EPS of $2.22 versus ~$2.09-$2.10 expected and gross margin of 75.0% [2][8]. The quality of the beat matters — GAAP EPS of $2.46 was inflated by a one-time $7.8 billion gain on equity securities that should be excluded from any assessment of underlying earnings power; the core beat rests on revenue and margin, not investment marks [11]. Data Center revenue of $89.0 billion (+117% YoY) drove the quarter, split between roughly $48.7-$49 billion of hyperscale demand and about $40 billion from AI Clouds, Industrial & Enterprise customers, and management guided fiscal Q3 to $108 billion ±2% while assuming zero China data-center compute revenue [3][9]. The balance sheet supports the growth story: $21.3 billion of quarterly free cash flow ($127.0 billion trailing twelve months), $62.5 billion cash against $38.9 billion debt, and about $26 billion returned to shareholders in the quarter via buybacks and dividends, alongside a modest $0.25 quarterly dividend yielding ~0.46% [5][6]. The bull side of the ledger centers on valuation and momentum. At $217.43 and a $5.25 trillion market cap [10], NVDA trades at roughly 27.9x trailing and 18.3x forward earnings with EV/EBITDA near 26x [1] — a substantial discount to peer AMD (forward P/E ~43-63x, EV/EBITDA near 80x) and toward the low end of NVDA's own multi-year P/E range, as earnings growth has outpaced the share price [12]. Wall Street reacted to the print by adding more than $400 billion in market value (an ~8.7% surge on August 27-28), driven partly by calendar-2027 revenue growth guidance of about 70% — nearly double what analysts had modeled [4]. Consensus stands at Strong Buy from 60 analysts (48 Strong Buy, 9 Buy, 2 Hold, 1 Strong Sell) [13], with an average target of $325.99 and median of $315, roughly 45-50% above the current price [14]; post-earnings raises came from JPMorgan ($320) [15], Goldman Sachs ($300, though notably Neutral-rated) [17], Morgan Stanley ($300, Overweight) [18], Stifel ($315) and Phillip Securities ($300) [20], with BofA most bullish at $350 as a top pick [19]. The cautionary side is equally concrete. Guidance embeds gross margin slipping from 75.0% to 74.0%, and supply commitments more than doubled from $119 billion to $279 billion — primarily memory procurement — a forward cost and inventory-risk signal the market is now pricing [9]. The Q3 outlook's assumption of zero China data-center compute revenue removes one uncertainty but also caps a former growth vector [3]. The street-wide target range of $180 to $515 — a nearly 3x spread, with the low target below the current price — signals unusually wide disagreement about AI-capex-driven earnings power rather than settled consensus [7][14], and Barclays' $275 target sits well below the average [19]. Forward P/E estimates themselves diverge across providers (18.3x vs 24.5x), so the valuation picture depends on whose earnings estimates one trusts [1]. Technically, the stock entered earnings after a 7.5% seven-session decline and remains below its May 14, 2026 all-time high of $236.54, the key overhead resistance alongside ~$231-232 [16]; it trades above both its 50-day ($208.42) and 200-day ($195.83) moving averages in an uptrend on both timeframes [22], with pre-earnings RSI near 52.3 — neutral momentum [23] — and post-earnings support identified around $207.58-$209.43 and nearer-term at ~$217, though these levels carry low confidence [24]. Six-month performance of +27.4% modestly outpaced the semiconductor industry's +25.1%, while the trailing-12-month total return was ~20.9% [21].

Figures as of Sep 1, 2026 · 19 days ago

Apple enters mid-July 2026 in price discovery at record highs, closing at an all-time high of $333.26 on July 16 for a ~$4.89T market cap [2][7], having added ~15% (~$600B) since June 25 [8]. The rally rests on genuine operational strength: fiscal Q2 2026 delivered record revenue of $111.2B (+16.6% YoY) and EPS of $2.01 (+22% YoY), beating consensus with no material one-time items flagged, driven by iPhone 17 demand and Services [3], alongside a dividend raise and expanded buybacks [11]. The balance sheet is robust — ~$129.2B TTM free cash flow against $84.7B debt in a net cash position [4] — and the near-term narrative is supported by China's regulator approving Apple Intelligence [8], investor approval of a low-capex 'AI restraint' strategy [21], and target raises from Morgan Stanley ($330→$360) [6], Citi ($365) [21], and TD Cowen/Bernstein ($350) [15]. Momentum is bullish but not yet stretched: price sits well above the 50-day (~$296–299) and 200-day (~$272–300) moving averages in a golden-cross posture [19], with 14-day RSI at ~64.3, below the 70 overbought line [20]. The hold-and-be-cautious case centers on valuation and target math. Apple's TTM P/E of ~38–40x sits roughly 42% above its 10-year median of 26.83 and near the top of its 5-year range [1][5], with EV/EBITDA of ~28–30x and price-to-book of ~45x [10] — a marked premium to peer Microsoft's ~16x EV/EBITDA and ~6.7x P/B, even though Apple out-earns MSFT on free cash flow (~$129B vs ~$73B) [12]. Critically, the stock has run past most analyst targets: average 12-month targets cluster in the low-to-mid $320s ($316–$329) [9], the median is ~$310 [22], and both figures sit at or below the ~$330–333 spot price, implying limited-to-negative net upside [16]. Several bank targets bracket or fall below current levels — JPMorgan $325 and UBS Neutral $296 [15] — and KeyBanc set a bearish $250 target on July 14, ~24% below spot [23]. The dividend yields just ~0.32%, near a historic low driven by the elevated price [11]. On balance, the evidence is genuinely two-sided: strong, non-recurring-free earnings, record cash generation, and clear AI catalysts justify the momentum, while an elevated multiple versus Apple's own history and a peer, plus a consensus average target now trailing the share price, argue the good news may be substantially priced in. The unusually wide target dispersion — from KeyBanc's $250 and lows near $215 up to a $400 high [14] — signals real disagreement, with an earnings report due July 30 (against a four-quarter beat streak that sets a high bar) as the next test [21].

Figures as of Jul 17, 2026 · 65 days ago

Amazon enters mid-July 2026 at $254.96 (market cap ~$2.74T, EV ~$2.84T) [6, 19] with a fundamental picture that is genuinely two-sided. The bull case rests on AWS: Q1 2026 revenue of $181.5B (+17% y/y) and AWS revenue of $37.6B growing 28% — its fastest pace in 15 quarters — with AWS operating income of $14.2B versus $11.5B a year earlier, backed by a $364B backlog and AI partnerships with OpenAI and Anthropic [1, 13]. Headline valuation looks reasonable by Amazon's own standards: the ~30.5x trailing P/E sits near the low end of its 5-year range (versus 51.5x in FY2021 and 52.4x in FY2023), and EV/EBITDA of 18.2x is mid-range [7, 23]. The bear case is equally concrete. Roughly half of Q1 net income came from a one-time, non-cash $16.8B pre-tax gain from marking the Anthropic investment to fair value, so the $2.78 reported EPS (versus ~$1.64 consensus) substantially overstates operating earnings power — and it also flatters that trailing P/E [2, 23]. Meanwhile, free cash flow has collapsed: TTM FCF fell from $25.9B a year ago to $1.2B at the Q1 report and roughly -$2.5B currently, driven by $44.2B of Q1 capex (~$151B TTM, tracking toward ~$200B for 2026), with $235.5B of total debt against $143.1B of cash and a ~$25B long-term bond sale launched in July to fund AI infrastructure [3, 14]. Versus Microsoft, Amazon commands a premium on earnings multiples (trailing P/E ~30.5 vs. 23.6, forward ~30.5 vs. 21.4, EV/EBITDA 18.2 vs. 16.2), though its P/B of 6.2 is below MSFT's 7.1 and it pays no dividend versus MSFT's 0.92% yield [8]. Wall Street leans decisively bullish but with real dispersion. The consensus is Strong Buy from 65 analysts (47 Strong Buy / 15 Buy / 3 Hold / 0 Sell) [16], with an average target of $314.27 and median of $315 — roughly +23% implied upside — corroborated by independent aggregators clustering in the $306–$320 range [9, 10]. July alone saw KeyBanc raise its target to $335, Wedbush initiate at Buy/$293, Jefferies maintain Buy/$320, TD Cowen at $340, Needham at $300, plus Wells Fargo Overweight/$313, BofA Buy/$310 citing AWS pricing power, and Citi Buy/$320 [4, 18]. Even the most conservative recent bank target (Wedbush's $293) sits ~15% above the market price [19]. But the target range spans $207 to $370 — a ~$163 spread signaling meaningful disagreement, with the Street-low implying ~19% downside [17, 22]. Technically, the stock is in a corrective posture within a bullish structure: it closed ~5.2% below its 50-day moving average (~$254.20–$254.60) but above its 200-day (~$233.17–$233.21), with a May golden cross intact [5], RSI(14) neutral at ~46.6–49.4 [11], and the shares ~7–10% below the May 6 all-time closing high of $274.99 [12, 20]. Cited levels to watch are resistance at $259.90 (a breakout targets ~$278.70) and trend-invalidation support at $229.50 near the 200-day average [24]. Bottom line, presented as balanced evidence rather than a recommendation: the strongest bull case is AWS re-acceleration to 28% growth with expanding segment income, reported cloud pricing power, and headline multiples near 5-year lows [13, 22, 23]; the strongest bear case is that trailing earnings are inflated by the $16.8B non-cash Anthropic gain, TTM FCF has gone negative on ~$151B of AI capex, leverage is rising via the ~$25B bond sale, and the stock still trades at a ~30% P/E premium to Microsoft [2, 3, 8, 14, 15]. What would change the conclusion: bearish if AWS growth decelerates or the capex wave fails to convert into AWS revenue and margin; bullish if capex crests while AWS momentum holds, restoring free cash flow [15]. The near-term test is Q2 2026 earnings on July 30, with consensus at $1.82 EPS on $196.02B revenue [21] — a print that will directly inform whether the capex-to-AWS-growth conversion thesis is on track.

Figures as of Jul 16, 2026 · 66 days ago

Alphabet enters mid-July 2026 with exceptional operating momentum set against a valuation that has moved well above its own history. The bull case rests on Q1 2026 results — revenue of $109.9B (+22%), operating income of $39.7B (+30%, 36.1% margin), and Google Cloud up 63% to $20.0B [1] — plus a uniformly positive Wall Street backdrop: a Strong Buy consensus from 64 analysts with zero sells [10], an average 12-month target of $431.72 (~16% above the July 15 close of $370.92) [11], no notable downgrades in ~90 days [22], and only upward target revisions post-Q1 (JPMorgan to $460, Piper Sandler to $445, Goldman still at $440 despite a $10 trim) [19][20][21][23]. Sentiment was further boosted by Warren Buffett confirming he initiated Berkshire's $31B+ stake and Wedbush assuming coverage at Outperform/$445, driving the July 15-16 pop (+3.17% plus ~2% pre-market) [14]. The company also holds a net cash position ($126.8B cash vs. $95.9B debt) and raised its dividend 5% to $0.22/quarter [6], and antitrust risk narrowed after the September 2025 remedies ruling rejected Chrome divestiture [16]. The bear case centers on cash flow and price. Q1 free cash flow collapsed to $10.1B (vs. $45.8B operating cash flow) as capex surged toward a raised $180-190B 2026 guide [5], and secondary-source consensus puts 2026 FCF around $20.5B — down roughly 72% from $73.3B in 2025 [15]. Meanwhile the stock trades at ~27-28x trailing and ~28-29x forward earnings [3], several turns above its own ~5-year average of ~22.9 [4], and at a significant premium to Microsoft (forward P/E ~28x vs. ~21x; EV/EBITDA ~26x vs. ~16x) — a reversal of the historical pattern where Alphabet was the cheaper megacap [9]. Headline earnings quality also needs normalization: Q1 net income of $62.6B (+81%) far exceeded operating income, implying $20B+ of non-operating gains (likely largely unrealized mark-to-market investment gains), so the 82% EPS growth substantially overstates the 30% underlying operating growth [17]. After roughly doubling over 12 months ($180.48-$408.61 52-week range) [24], even the most bearish published target ($340) sits less than 10% below the market price [7], leaving little cushion in the consensus view if the AI-capex bet disappoints. Technically the stock is back above both its 50-day (~$351) and 200-day (~$365) moving averages after the rally, with the 200-day EMA near $316 confirming the longer-term uptrend [12]; resistance sits at the May 13 all-time closing high of $402.38 and the intraday high of $408.61 [13], while RSI readings are conflicting but broadly neutral-to-elevated [25]. Key risks beyond capex include a new publisher copyright lawsuit, Gemini co-lead Noam Shazeer's departure to OpenAI, and ad-competition threats [16]. What would change the picture most is the Q2 2026 report on July 22 (consensus revenue ~$113-116B, EPS ~$2.86-2.87) [15][18]: continued 60%+ cloud growth and resilient AI-enhanced search monetization would support the premium multiple and the $431-460 target cluster [19][23], whereas any deceleration, a further capex raise, or deeper FCF compression would pressure a stock priced meaningfully above its historical norm [4][5]. Balanced bottom line: the growth evidence is unusually strong and sentiment unanimous, but the valuation premium, near-term FCF collapse, and one-time-inflated headline EPS mean the reward-to-risk hinges heavily on the imminent earnings print — the evidence supports both a durable-AI-winner reading and a priced-for-perfection reading, and the reader must weigh them.

Figures as of Jul 16, 2026 · 66 days ago

JPMorgan enters mid-July 2026 at a record high — $346.91 on July 15, near the top of its $279.10–$351.24 52-week range [4][6] — powered by a Q2 print that beat consensus on every headline line: reported EPS of $7.70 versus ~$5.55–$5.59 expected, revenue of $57.3B versus ~$49.9B, an 86% surge in equity-markets revenue to $6.0B within record $12.1B total Markets revenue, and investment-banking fees up 30% to $3.3B, the best since 2021 [3]. The strongest bull case rests on the quality of the underlying business even after stripping one-time items: excluding $5.6B of pretax gains (a $4.6B Visa share gain plus ~$1.0B of equity-investment gains), normalized EPS of $6.14 still beat the ~$5.44–$5.74 consensus and normalized net income of $16.9B was up about 13% year over year [5][7], with broad-based momentum — revenue up ~15% ex-items, net interest income up ~10% to $25.6B [14] — plus a dividend raise to $1.65/quarter effective Q3 [15] and a market paying up for ~23% ROTCE, best-in-class among money-center peers [1]. The strongest bear case is that this excellence is already fully priced, and then some. Roughly $1.56 of the $7.70 headline EPS was non-recurring, meaning trailing EPS ($23.30) and the ~14.9x trailing P/E are flattered by one-time gains [5][8]; on cleaner comparisons JPM trades at ~16.4x versus its own 12-month average of 15.3x, a 14.3x large-bank peer average, and a 12.2x industry average [2], and its 2.61x price-to-book towers over Bank of America's ~1.54x despite BAC posting its own strong quarter ($9.1B net income, +27%; EPS $1.21, +34%) [1]. The Street's positioning reflects this tension: 12 of 24 S&P Global-polled analysts sit at Hold [9], and average targets of $353.57–$364.81 (depending on aggregator) imply only ~2–5% upside from the July 15 close — the post-earnings target raises have largely been absorbed by the rally [10][16][17]. Key near-term risks include the raised full-year expense guidance to $107.5B from $105B, which initially knocked shares down more than 2.5% premarket before the revenue beat prevailed [20], rising expenses (+15% to $27.3B) and ~$2.4B of net charge-offs [14], and the durability question on the trading/IB windfall — the explicit swing factor analysts cite between the $420/$408 high targets and Baird's $305 low [10][17]. Bottom line on valuation and what changes the conclusion: the stock is priced for sustained best-in-class profitability — technically constructive (price ~10–14% above the 50-day and ~12% above the 200-day MA, RSI ~59.6 and not yet overbought, old $343.45 resistance now potential support with staged supports at $325/$316/~$310) [12][13][19] but fundamentally at a premium on P/E versus peers and its own recent history, and at a rich P/B for a US money-center bank [2][21]. The bull case strengthens if the capital-markets surge proves durable rather than episodic and normalized earnings keep compounding at the ~13% Q2 pace, which would push targets toward the $408–$420 high end [7][17]; the bear case strengthens if trading/IB revenue normalizes while the $107.5B expense trajectory holds, inviting multiple compression toward the 14.3x peer average and validating the $305 low target [2][17][20]. Watching normalized (ex-items) EPS trends, the expense guide, and whether Markets revenue holds near the $12.1B record are the specific tells that would change the conclusion either way [7][14][20].

Figures as of Jul 16, 2026 · 66 days ago

TQQQ (ProShares UltraPro QQQ) trades near $74.44 as of the July 15, 2026 close (down 0.77% on the day), with roughly $34–36 billion in assets and a beta of 3.70 [3][7]. The fund has delivered a 77.10% trailing 12-month total return versus 29.66% for its unleveraged peer QQQ — about 2.6x rather than 3x the index, quantifying the volatility-decay and fee drag inherent to daily-reset leverage [5]; a second aggregator pegs the TTM figure at +68–75% with +38.3% YTD, the spread reflecting measurement-window sensitivity [17]. The rally was driven mechanically by the Nasdaq-100's 33%+ surge between March 30 and June 2, 2026 and ~26% first-half gain on the AI-infrastructure trade [10]. Traditional fundamentals (P/E, revenue, EPS, FCF) do not apply to the fund itself — it holds Nasdaq-100 index swaps, not an operating business [4] — so valuation properly attaches to the underlying index, which trades at a 31.89 trailing P/E versus a 28.9 long-term average and a 27.44 forward P/E as of January 1, 2026: above average, but below prior peaks near 38.8 [11]. Costs are a live issue: the 0.82–0.84% net expense ratio (0.97% gross) relies on a fee waiver expiring September 30, 2026, versus 0.18% for QQQ [1]; the ~0.49–0.51% distribution yield derives from swap-collateral interest, not a managed dividend policy [2]. There is no direct Wall Street view on TQQQ: zero analyst ratings, no consensus price target, and no upgrades or downgrades in the past 90 days, because sell-side banks do not cover leveraged ETFs [6]. The closest proxies are look-through measures: MarketBeat's holdings-weighted 'Moderate Buy' (score 2.82 from 615 ratings on 14 top holdings covering ~17.8% of the fund) [13], and TipRanks' 'Strong Buy' consensus on QQQ (88 Buy / 12 Hold / 1 Sell) with an $857.18 average target implying ~19% upside from QQQ's $717.74 close — upside that cannot be linearly tripled for TQQQ because daily resets make outcomes path-dependent [15][16]. Algorithmic forecast sites publish 2026 projections averaging $121.31 ($90.25–$152.37), but these are trend extrapolations with no fundamental grounding and low reliability [21]. Technically, the picture is mixed: the fund sits about 13% below its $88.09 52-week high but roughly double its $37.32 low [9], trading essentially at its 50-day moving average (~$76.39) and ~12% above its 200-day (~$68.09) [8]. A bearish 10/50-day moving-average crossover fired July 6, 2026 even as longer-horizon composites (12 buys, 0 sells) remained bullish [20]; RSI(14) readings conflict (69.0 vs 49.9), consistent with momentum cooling from overbought June into neutral July [18]. Support sits near $76.00, $71.48–$71.83, and $69.27; resistance near $77.19 and $78.37 [19]. Bottom line, presented as balanced evidence rather than a recommendation. The strongest bull case: a continued low-volatility Nasdaq-100 uptrend, where daily-reset compounding works in holders' favor — the mechanism behind the past year's 77% return — supported by AI-cycle catalysts like Broadcom's guided Q3 AI semiconductor revenue of $16.0 billion (+200% YoY) and the Broadcom–Apple partnership extension to 2031 that lifted the index ~1.3% [12][14][10]. The strongest bear case: 3x leverage is currently applied to an above-average index multiple (31.9x trailing vs 28.9x average), so any sustained drawdown or choppy sideways market is magnified roughly threefold daily and compounding turns into decay [12][11][5]. Key risks layered on top: Bloomberg reports tech call options at their priciest relative to the S&P 500 since 2007 — a speculative-froth signal directly relevant to a 3x long fund [14]; the fee-waiver expiration on September 30, 2026 could modestly raise costs [1]; and rate shifts alter the swap-financing costs embedded in the structure [12]. Where valuation stands: above-average but not extreme on the underlying index, with the QQQ proxy consensus labeling the index 'Undervalued' versus aggregated targets — a tension the reader must weigh [11][16][15]. What would change the conclusion: index multiples compressing back toward the ~28.9 average (reducing valuation risk), a sustained rise in realized volatility without direction (worsening decay), non-renewal of the fee waiver, materially cut or raised consensus targets on mega-cap holdings, or the start of actual sell-side coverage of the ETF [12][21].

Figures as of Jul 16, 2026 · 66 days ago

Where valuation stands today: Bitcoin trades around $58,300–$58,600 with a market cap near $1.18 trillion [1], after falling roughly 20% in June 2026 (opening near $73,500, closing near $58,500) [5] and roughly 43.7% over the trailing 12 months [12] — well below the 2025 all-time high near $126K [11]. Unlike equities, BTC has no earnings-based valuation; its 'fundamentals' are supply/issuance, network security, and flows. The proximate drivers of the drawdown were record spot-ETF outflows (a ~$3.4B single-week record, the largest since the January 2024 launch, with ~$4.5B redeemed across June — the worst month on record, including a 13-day outflow streak of ~$4.4B) [4][6], a hawkish Fed repricing that pushed the 10-year Treasury yield up ~18bps to ~4.82% and rate cuts toward 2027 [10], and profit-taking as a ~34% two-month rally that peaked near $74,500 in late May reversed ~22% [9]. Geopolitical stress (the reported 103rd day of the U.S.-Israel–Iran conflict and an oil-price spike) added risk-off pressure, though on a single, low-confidence source [15].

Figures as of Jul 1, 2026 · 81 days ago

Valuation and tokenomics: As of 2026-07-01 SOL trades near $73 (aggregator band ~$72.69–$74.61) for a market cap of ~$42.7B and FDV of ~$46.3B, ranking #7 [1][4][5]. With ~580.9M of ~629.5M tokens circulating (~92.3%) and an uncapped, inflationary supply, the market-cap-to-FDV ratio sits near 0.92 — only ~8% overhang, and most future dilution comes from ongoing ~3.77% inflation (disinflating 15%/yr from an 8% start toward a 1.5% floor) rather than large unlock cliffs [3][6][7][9][15]. The FTX/Alameda estate's residual ~5M locked SOL is under ~1% of float, so the unlock overhang is modest [8]. About 67.9% of supply (~427M SOL) is staked at ~5.5–6.5% APY, and SOL's market cap is roughly 22% of Ethereum's ~$190.1B [2][3][22]. Note one same-source snapshot lists a slightly higher $43.4B cap / $47.0B FDV, illustrating intra-day aggregator variance [12]. Bull case (network health, catalysts, technicals): Solana posts strong usage — a record ~2.1M daily active addresses and ~238.5M daily transactions at the highest throughput among major L1s (~$0.00025/tx), SOL-denominated TVL at an all-time high above 80M SOL in Feb 2026, a record ~11,534 new developers, and 2,100+ active dApps [16][17][19]. Institutional access is the marquee catalyst: U.S. spot SOL ETFs launched ~Oct 2025 (BSOL, FSOL) with ~$1.3–1.45B cumulative inflows, Morgan Stanley filings in Jan 2026, and Alpenglow/Firedancer upgrades cited as supportive, with SEC deadlines mid-to-late 2026 [13][20]. Technically the posture is mildly bullish/neutral: spot sits fractionally above the 50-day (~$72.12) and 200-day (~$71.62) averages, RSI(14) reads a neutral ~52–62, and SOL is up ~50.3% over 12 months [5][11][21]. Bear case, key risks, and what would change the read: The core bear signal is weak value capture — of ~$10M daily ecosystem fees only ~$100k accrues to the protocol, and monthly Real Economic Value collapsed ~95% from ~$550M (Jan 2025) to ~$23.5M (Dec 2025), suggesting much 2025 activity was speculative [18]. USD DeFi TVL fell from ~$9B to ~$5.5–6B after the April 2026 Drift exploit, and SOL remains ~74.6% below its $293.31 ATH (Jan 2025) [11][17]. The proposed SIMD-0550 (not enacted) could accelerate disinflation and cut modeled staking yields to ~4.3% in year one and ~2.25% by year three, and ~600k SOL flowing to exchanges leaves holder-flow direction genuinely mixed against concurrent whale accumulation [14][24]; regulatory outcomes (CLARITY/GENIUS Act, pending SEC decisions) remain open [20]. On the balance point: a weekly close above $73.50 opens $75–$80, while losing $71.50 exposes $68, then $64 and the $60 June floor — with sustained ETF inflows vs. outflows the specific factor most likely to flip the balanced read [10][13][23].

Figures as of Jul 1, 2026 · 81 days ago

Price/technical state: As of June 7, 2026, DOGE trades around $0.083-$0.085 with a market cap of roughly $13-14.3B (rank #10-11) and ~$0.68-0.76B in 24h volume. The picture is bearish in the near term. DOGE is down ~16% over 7 days and ~23-30% over 30 days, having broken a descending channel near June 4 amid a sector-wide memecoin selloff (BONK, PEPE, SHIB also fell). Six-month return is roughly -40% and the 12-month return is contested (~-52% to -63% on some trackers, though CoinGecko shows +54% on a 1y basis depending on the start date), reflecting how much DOGE has retraced from its late-2024/early-2025 highs. Price sits well below both its 50-day MA (~$0.10-0.11) and 200-day MA, a bearish alignment, and RSI(14) is near 30 (oversold). Near-term support clusters around $0.080-0.082 with resistance near $0.095-0.105. Bull case: DOGE retains deep liquidity, the strongest meme-coin brand, and is now nearly 4x Shiba Inu's market cap (~$13-14B vs ~$3.6B) with far higher turnover. In March 2026 the SEC and CFTC jointly classified DOGE as a digital commodity (one of 16 named assets), removing the main legal barrier to spot ETFs and shifting oversight toward the lighter-touch CFTC. Multiple U.S. spot/derivative ETF wrappers now exist (REX-Osprey DOJE since Sept 2025; 21Shares TDOG on Nasdaq since Jan 2026, 0.50% fee; Grayscale and Bitwise products auto-launched in late 2025), giving regulated access. Payments adoption has incrementally improved: Tesla reinstated DOGE for merchandise/Cybertruck accessories in 2026, the Dallas Mavericks accept it, and Musk's X Money launch is a sentiment driver. Whale wallets reached multi-year/all-time highs in 2026 (e.g., ~108B+ DOGE held by the largest cohort per Santiment), framed by some as professional accumulation. Tokenomics are disinflationary: a FIXED 5B DOGE/year tail emission (10,000 DOGE/block, ~1-min blocks) means the inflation rate keeps falling (~3.2% now, toward ~2% by ~2040), and ~70%+ of security comes free via merged mining with Litecoin. Bear case/risks: DOGE has no max supply and perpetual issuance, so demand must absorb ~5B new coins every year indefinitely. ETF demand has been tiny: combined U.S. DOGE-ETF AUM was only ~$14.7M as of mid-May 2026 (DOJE ~$18-20M, TDOG ~$4M), a fraction of BTC/ETH ETF scale, and several sessions in late May 2026 saw zero daily flows. Ownership is extremely concentrated: the top 100 addresses hold ~66-67% of supply, the top 10 ~45-60%, and the single largest wallet (Robinhood's cold wallet) holds ~27.2B DOGE, ~18% of supply (the famous ~28-30B address; it is custodial user funds, not one whale). On-chain usage is modest relative to market cap (~30,000 active addresses/day, ~22,000 tx/day, ~$110M transferred), with most volume speculative; developer activity and native utility remain low versus Ethereum/Solana. DOGE stays heavily dependent on Musk/X headlines and broad memecoin sentiment, making it prone to sharp reversals. This report is informational only and is not a buy or sell recommendation.

Figures as of Jun 7, 2026 · 105 days ago

As of June 7, 2026, Ethereum (ETH) trades around $1,628 with a market cap of roughly $190-197 billion, the #2 crypto asset behind Bitcoin. The defining fact of the past year is severe price weakness: ETH is down ~65-67% from its August 24, 2025 all-time high near $4,950, having bottomed around $1,390-$1,735 in late May/early June 2026 before a sharp oversold bounce (+~19% over 7 days, +~30% over 30 days). It has also badly underperformed Bitcoin, with the ETH/BTC market-cap ratio compressed to ~0.14-0.15 and ETH dominance near 8.9% versus BTC's ~56%. Technically the bounce lifted ETH back above its 50-day moving average (~$1,590) but it remains below the 200-day (~$1,815) in a confirmed death-cross structure; RSI(14) has recovered from oversold (~33 on June 3) to neutral (~58 on June 7). Support sits at $1,600-$1,650 (floor cluster ~$1,400); resistance at $1,800-$1,820, then $2,000. The bull case rests on fundamentals and regulatory clarity. On March 17, 2026, the SEC and CFTC issued a binding joint interpretive release classifying ETH as a 'digital commodity' (not a security) under CFTC oversight, and explicitly held that staking is not a securities transaction — unlocking staking-enabled spot ETH ETFs. Cumulative U.S. spot-ETH-ETF net inflows since launch stand near $11-12B (BlackRock's ETHA ~47% of flows). Staking hit a record ~39.5M ETH (~32% of supply, ~1.1M validators) at a ~2.9-3.3% yield, with a large validator entry queue and a near-empty exit queue signaling structural demand to lock up supply. The network is the largest by almost every measure: ~$45.5B L1 DeFi TVL (still ~53% of all DeFi), the largest developer base (~31,000 builders), and active addresses near multi-year highs (~586-590k/day). The technical roadmap is executing — Fusaka (PeerDAS, EIP-7594) went live December 3, 2025, with Glamsterdam targeted for H1 2026. The bear case is a value-accrual problem. Post-Dencun (March 2024), activity and fees migrated to Layer-2s, collapsing mainnet fee revenue (daily L1 fees down ~40% YoY) and the EIP-1559 burn, so ETH is now mildly inflationary (~+0.2% net annual issuance) rather than 'ultrasound money.' L2s capture most of the economic value while paying Ethereum only a small blob fee (e.g., Base earned ~$94M profit but paid ~$4.9M in blob fees), and Vitalik Buterin has conceded the original L2 vision 'no longer makes sense' — restoring ETH's value capture is the central open question. Competition is intensifying (Solana DEX volumes have at times exceeded Ethereum L1), DeFi dominance has slipped from ~63% to ~53%, and security risk remains live — 2026 DeFi/bridge exploits exceeded $750M by April, led by the ~$292M Kelp DAO bridge hack (April 18, 2026, attributed to Lazarus Group). On balance, ETH is the dominant, now-regulated smart-contract settlement layer trading ~65% off its highs, but its 6-24 month re-rating depends on whether L2 scaling translates into measurable ETH value accrual rather than cannibalizing it.

Figures as of Jun 7, 2026 · 105 days ago